Core Viewpoint - A total of 9 companies submitted applications to the Hong Kong Stock Exchange from May 19 to May 25, with 1 company passing the hearing, 5 companies undergoing initial public offerings (IPOs), and 3 companies listing [1]. Group 1: Companies Submitting Applications - Fuwai Group Limited, a pan-Asian life insurance company, reported a projected net profit of $10 million for 2024, recovering from previous losses [2]. - Shandong Kuailu Technology Development Co., Ltd. focuses on short-distance green travel solutions, with a market share of 2.2% in mainland China's short-distance green travel technology services [3]. - Jushuitan Group Co., Ltd. is the largest e-commerce SaaS ERP provider in China, holding a 20.7% market share [4]. - Sany Heavy Industry Co., Ltd. ranks first in China and third globally in core engineering machinery revenue from 2020 to 2024, with a projected overseas market revenue share of 62.3% by 2024 [4][5]. - Lezi Tiancheng Cultural Development Co., Ltd. is the second-largest multi-category IP toy company in China, with revenues projected to grow from approximately 463 million RMB in 2022 to 630 million RMB in 2024 [6]. - Furuitek (Zhejiang) Intelligent Technology Co., Ltd. ranks second among third-party suppliers of intelligent driving solutions in China, with a market share of 7.2% [7]. - Shenzhen Huaxida Technology Co., Ltd. is a leading AI Home solution provider, ranking third in China by revenue [7]. - Kewang Pharmaceutical Group is a clinical-stage biopharmaceutical company with significant products in clinical development [8]. - Allianz International Holdings Limited is a Hong Kong security service provider with projected revenues of 114 million HKD in 2023 [9]. Group 2: Companies Passing Hearings and IPOs - Haitian Flavoring and Food Co., Ltd. is a leading condiment company in China, holding a 4.8% market share in the condiment market, which is projected to reach 498.1 billion RMB in 2024 [10]. - The company reported revenues of 25.61 billion RMB in 2022, with profits of 6.198 billion RMB [10]. Group 3: Companies Undergoing IPOs - Hengrui Medicine Co., Ltd. had a public offering that was oversubscribed by approximately 455 times, with a final issue price of 44.05 HKD per share [11]. - MIRXES-B had a global offering of 46.62 million shares, with a public offering oversubscription of 25.51 times [12]. - Jihong Co., Ltd. plans to issue 67.91 million shares, with a price range of 7.48 to 10.68 HKD per share [13]. - Paige Biopharma-B plans to issue 19.28 million shares at a price of 15.60 HKD per share [14]. - Shouhui Group plans to issue 24.36 million shares at a price range of 6.48 to 8.08 HKD per share [15]. Group 4: Companies Listing - CATL officially listed on the Hong Kong Stock Exchange with an opening price of 263 HKD per share, closing at 306.20 HKD, a 16.43% increase on the first day [16]. - MIRXES-B opened at 29 HKD per share and closed at 30 HKD, a 28.76% increase on its first day [17]. - Hengrui Medicine opened at 57 HKD per share and closed at 55.15 HKD, a 25.20% increase on its first day [18].